FDA Approved Drugs for Pharmacology/Toxicology

Drugs Approved in 2017

Actemra (tocilizumab) injection; Genentech; For the treatment of CAR T cell-induced severe or life-threatening cytokine release syndrome, Approved September 2017

Gocovri (amantadine) ; Adamas Pharmaceuticals; For the treatment of Parkinson's disease dyskinesia, Approved August 2017

Drugs Approved in 2016

Sustol (granisetron); Heron Therapeutics; For the prevention of chemotherapy-induced nausea and vomiting, Approved August 2016

Drugs Approved in 2015

Bridion (sugammadex); Merck; For the reversal of neuromuscular blockade induced by rocuronium and vecuronium in adults undergoing surgery, Approved December 2015

Drugs Approved in 2014

Akynzeo (netupitant and palonosetron); Helsinn; For the prevention of chemotherapy-induced nausea and vomiting, Approved October 2014

Bunavail (buprenorphine and naloxone); BioDelivery Sciences; For the maintenance treatment of opioid dependence, Approved June 2014

Movantik (naloxegol); AstraZeneca; For the treatment of opiod-induced constipation in adults with chronic non-cancer pain, Approved September 2014

Myalept (metreleptin for injection); Bristol-Myers Squibb; For the treatment of congenital or acquired generalized lipodystrophy, Approved February of 2014

Drugs Approved in 2013

Kcentra (Prothrombin Complex Concentrate); CSL Behring; For the reversal of vitamin K antagonist therapy-induced coagulation factor deficiency, Approved May 2013

Drugs Approved in 2012

Voraxaze (glucarpidase); BTG International; For the treatment of toxic plasma methotrexate concentrations in patients with impaired renal function, Approved January 2012

Drugs Approved in 2011

Oxecta (oxycodone HCl); Pfizer; For the management of acute and chronic moderate to severe pain, Approved June 2011

Drugs Approved in 2010

Egrifta (tesamorelin for injection); Theratechnologies; For the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy, Approved November 2010

Zuplenz (ondansetron oral soluble film); Strativa Pharmaceuticals; For the prevention of post-operative, chemotherapy and radiotherapy induced nausea and vomiting, Approved July 2010

Drugs Approved in 2008

Akten (lidocaine hydrochloride); Akorn; For anesthesia during ophthalmologic procedures, Approved October 2008

Fusilev (levoleucovorin); Spectrum Pharmaceuticals; For rescue after high-dose methotrexate therapy in osteosarcoma and to reduce the toxicity of methotrexate, Approved March of 2008

Sancuso (granisetron); ProStrakan; For the treatment of chemotherapy-induced nausea and vomiting, Approved September 2008

Drugs Approved in 2004

Campral (acamprosate calcium); Forest Laboratories; For the treatment of alcohol dependence and the maintenance of alcohol abstinence, Approved August, 2004

Drugs Approved in 2002

Mesnex; Bristol-Myers Squibb, Baxter Healthcare; Oral tablet to inhibit the hemorrhagic cystitis induced by Ifex (ifosfamide), Approved March 2002

Subutex/Suboxone (buprenorphine/naloxone); Reckitt Benckiser; Oral tablets for the treatment of opiate dependence, Approved October 2002

Drugs Approved in 1999

Raplon; Organon; Adjunct to general anesthesia during surgical procedures, Approved August 1999

Drugs Approved in 1997

AneuVysion Assay; Vysis; Genetic test for birth defects, Approved October 1997

Antizol Injection; Orphan Medical; Treatment for ethylene glycol poisoning, Approved December 1997

Galzin (zinc acetate); Teva Pharmaceutical; Treatment for Wilson’s disease, Approved January 1997

Kytril (granisetron) tablets; SmithKline Beecham; Prevention of nausea and vomiting associated with chemotherapy, Approved November 1997

Omnicef; Warner-Lambert; Treatment against various bacterias, Approved December 1997

Oxycodone with Acetaminophen 5mg/325mg; Watson Pharmaceuticals; Generic equivalent of Percocet and Tylox, Approved November 1997

Trovan; Pfizer; Treatment for bacterial infections, Approved December 1997

Drugs Approved in 1996

Iontocaine; Iomed; Needle-free anesthetic, Approved May 1996

Lamisil (terbinafine hydrochloride) Tablets; Sandoz Pharmaceuticals; Treatment for nail fungal infections, Approved May 1996

Nascobal Gel (Cyanocobalamin, USP); Questcor Pharmaceuticals; Treatment for vitamin B-12 deficiency, Approved November 1996